Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Total Liabilities came in at $2.2 billion in Q2 2026, down 2.46% on a YoY basis from $2.2 billion in Q2 2025, and up 1.54% quarter-over-quarter from $2.2 billion in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Total Liabilities for 5 consecutive years, with $2.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Liabilities fell 2.46% year-over-year to $2.2 billion; the trailing twelve-month figure through Jun 2026 stood at $2.2 billion (down 2.46% YoY), and the FY2025 full-year result was $2.2 billion, down 2.91% from the prior year.
- Total Liabilities improved to $2.2 billion in Q2 2026 per FTRE's latest filing, from $2.2 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $2.6 billion in Q1 2024 and bottomed at -$3.4 billion in Q1 2023.
- Historically, Total Liabilities has averaged $1.5 billion across 5 years, with a median of $2.2 billion in 2025.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities soared 178.98% in 2023, then decreased 19.22% in 2024.
- Over 5 years, Total Liabilities stood at $945.3 million in 2022, then soared by 177.0% to $2.6 billion in 2023, then decreased by 15.34% to $2.2 billion in 2024, then decreased by 2.91% to $2.2 billion in 2025, then climbed by 1.79% to $2.2 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $2.2 billion, $2.2 billion, and $2.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 23.58 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.62 Bn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 4.64 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 7.02 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 2.19 Bn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 1.06 Bn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 569.76 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 22.92 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 7.02 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 6.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.19 Bn |
| Mar 31, 2026 | 2.16 Bn |
| Dec 31, 2025 | 2.15 Bn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | 2.25 Bn |
| Mar 31, 2025 | 2.26 Bn |
| Dec 31, 2024 | 2.22 Bn |
| Sep 30, 2024 | 2.15 Bn |
| Jun 30, 2024 | 2.10 Bn |
| Mar 31, 2024 | 2.65 Bn |
| Dec 31, 2023 | 2.62 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 2.61 Bn |
| Mar 31, 2023 | -3.40 Bn |
| Dec 31, 2022 | 945.30 Mn |
| Jun 30, 2022 | -3.30 Bn |